Suppr超能文献

凝血因子Xa催化凝血酶原激活过程中中间凝血酶的形成。在纯化系统和血浆中的形成。

Meizothrombin formation during factor Xa-catalyzed prothrombin activation. Formation in a purified system and in plasma.

作者信息

Tans G, Janssen-Claessen T, Hemker H C, Zwaal R F, Rosing J

机构信息

Department of Biochemistry, University of Limburg, Maastricht, The Netherlands.

出版信息

J Biol Chem. 1991 Nov 15;266(32):21864-73.

PMID:1939210
Abstract

Meizothrombin and thrombin formation were quantitated during factor Xa-catalyzed activation of human prothrombin in reaction systems containing purified proteins and in plasma. In the purified system considerable amounts of meizothrombin accumulated when prothrombin was activated by factor Xa (with or without accessory components) under initial steady state conditions. The ratio of the rates of meizothrombin and thrombin formation was not influenced by variation of the pH, temperature, or ionic strength of the reaction medium. When 2 microM prothrombin was activated by the complete prothrombinase complex (factor Xa, factor Va, Ca2+, and phospholipid) 80-90% of the initially formed reaction product was meizothrombin. Lowering the prothrombin concentration from 2 to 0.03 microM caused a gradual decrease in the ratio of meizothrombin/thrombin formation from 5 to 0.6. When the phosphatidylserine content of the phospholipid vesicles was varied between 20 and 1 mol % and prothrombin activation was analyzed at 2 microM prothrombin the relative amount of meizothrombin formed decreased from 85 to 55%. With platelets, cephalin, or thromboplastin as procoagulant lipid, thrombin was the major reaction product and only 30-40% of the activation product was meizothrombin. We also analyzed complete time courses of prothrombin activation both with purified proteins and in plasma. In reaction systems with purified proteins substantial amounts of meizothrombin accumulated under a wide variety of experimental conditions. However, little or no meizothrombin was detected in plasma in which coagulation was initiated via the extrinsic pathway with thromboplastin or via the intrinsic pathway with kaolin plus phospholipid (cephalin, platelets, or phosphatidylserine-containing vesicles). Thus, thrombin was the only active prothrombin activation product that accumulated during ex vivo coagulation experiments in plasma.

摘要

在含有纯化蛋白的反应体系以及血浆中,对人凝血酶原在因子Xa催化激活过程中形成中间凝血酶和凝血酶的情况进行了定量分析。在纯化体系中,当凝血酶原在初始稳态条件下被因子Xa(有无辅助成分)激活时,会积累大量中间凝血酶。中间凝血酶和凝血酶形成速率的比值不受反应介质pH值、温度或离子强度变化的影响。当2微摩尔/升的凝血酶原被完整的凝血酶原酶复合物(因子Xa、因子Va、Ca²⁺和磷脂)激活时,最初形成的反应产物中有80 - 90%是中间凝血酶。将凝血酶原浓度从2微摩尔/升降至0.03微摩尔/升,导致中间凝血酶/凝血酶形成的比值从5逐渐降至0.6。当磷脂囊泡中磷脂酰丝氨酸的含量在20%至1%之间变化,且在2微摩尔/升凝血酶原浓度下分析凝血酶原激活情况时,形成的中间凝血酶的相对量从85%降至55%。以血小板、脑磷脂或凝血活酶作为促凝脂质时,凝血酶是主要反应产物,只有30 - 40%的激活产物是中间凝血酶。我们还分析了纯化蛋白和血浆中凝血酶原激活的完整时间进程。在含有纯化蛋白的反应体系中,在多种实验条件下都会积累大量中间凝血酶。然而,在通过凝血活酶经外源性途径或通过高岭土加磷脂(脑磷脂、血小板或含磷脂酰丝氨酸的囊泡)经内源性途径启动凝血的血浆中,几乎检测不到中间凝血酶。因此,在血浆的体外凝血实验中,凝血酶是唯一积累的活性凝血酶原激活产物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验